8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Copper(II) binding properties of hepcidin

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hepcidin is a peptide hormone that regulates the homeostasis of iron metabolism. The N-terminal domain of hepcidin is conserved amongst a range of species and is capable of binding Cu II and Ni II through the amino terminal copper–nickel binding motif (ATCUN). It has been suggested that the binding of copper to hepcidin may have biological relevance. In this study we have investigated the binding of Cu II with model peptides containing the ATCUN motif, fluorescently labelled hepcidin and hepcidin using MALDI-TOF mass spectrometry. As with albumin, it was found that tetrapeptide models of hepcidin possessed a higher affinity for Cu II than that of native hepcidin. The log K 1 value of hepcidin for Cu II was determined as 7.7. Cu II binds to albumin more tightly than hepcidin (log K 1 = 12) and in view of the serum concentration difference of albumin and hepcidin, the bulk of kinetically labile Cu II present in blood will be bound to albumin. It is estimated that the concentration of Cu II-hepcidin will be less than one femtomolar in normal serum and thus the binding of copper to hepcidin is unlikely to play a role in iron homeostasis. As with albumin, small tri and tetra peptides are poor models for the metal binding properties of hepcidin.

          Electronic supplementary material

          The online version of this article (doi:10.1007/s00775-016-1342-2) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Hepcidin and iron regulation, 10 years later.

          Tomas Ganz (2011)
          Under evolutionary pressure to counter the toxicity of iron and to maintain adequate iron supply for hemoglobin synthesis and essential metabolic functions, humans and other vertebrates have effective mechanisms to conserve iron and to regulate its concentration, storage, and distribution in tissues. The iron-regulatory hormone hepcidin, first described 10 years ago, and its receptor and iron channel ferroportin control the dietary absorption, storage, and tissue distribution of iron. Hepcidin causes ferroportin internalization and degradation, thereby decreasing iron transfer into blood plasma from the duodenum, from macrophages involved in recycling senescent erythrocytes, and from iron-storing hepatocytes. Hepcidin is feedback regulated by iron concentrations in plasma and the liver and by erythropoietic demand for iron. Genetic malfunctions affecting the hepcidin-ferroportin axis are a main cause of iron overload disorders but can also cause iron-restricted anemias. Modulation of hepcidin and ferroportin expression during infection and inflammation couples iron metabolism to host defense and decreases iron availability to invading pathogens. This response also restricts the iron supply to erythropoietic precursors and may cause or contribute to the anemia associated with infections and inflammatory disorders.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Inorganic and bioinorganic solvent exchange mechanisms.

                Bookmark

                Author and article information

                Contributors
                sukhi.bansal@kcl.ac.uk
                Journal
                J Biol Inorg Chem
                J. Biol. Inorg. Chem
                Journal of Biological Inorganic Chemistry
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0949-8257
                1432-1327
                16 February 2016
                16 February 2016
                2016
                : 21
                : 329-338
                Affiliations
                [ ]Faculty of Pharmacy, Payap University, Mae Khao Campus, Chiang Mai, Thailand
                [ ]Institute of Pharmaceutical Science, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH UK
                [ ]Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200 Thailand
                Article
                1342
                10.1007/s00775-016-1342-2
                4850187
                26883683
                d7c2748a-b309-4418-b0f2-3db880f169e2
                © The Author(s) 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 27 August 2015
                : 2 February 2016
                Categories
                Original Paper
                Custom metadata
                © SBIC 2016

                Inorganic & Bioinorganic chemistry
                peptide,mass spectrometry,homeostasis,binding affinity,biomedicine

                Comments

                Comment on this article